The Indian Institute of Technology Guwahati (IIT-G) has signed a Memorandum of Understanding (MoU) to promote its cutting-edge C-Phycocyanin (C-PC) production technology, aiming to revolutionize the health and pharmaceutical industries. C-Phycocyanin, a natural blue pigment derived from Spirulina, is known for its potent antioxidant, anti-inflammatory, and neuroprotective properties, making it highly valuable for pharmaceutical, nutraceutical, and cosmetic applications.
The collaboration focuses on scaling up the production of high-purity C-PC using IIT-G’s advanced biotechnological innovations. This sustainable, cost-effective production method enhances the commercial viability of C-PC, paving the way for its widespread use in therapeutic formulations, immune-boosting supplements, and anti-cancer treatments.
Researchers at IIT-G highlight the growing global demand for natural, plant-based bioactive compounds, positioning C-PC as a promising alternative to synthetic dyes and pharmaceutical additives. The MoU aims to facilitate industry partnerships, enabling mass production and commercialization of this high-value biomolecule.
Through this initiative, IIT-G reinforces its commitment to bridging scientific research with industry applications, fostering innovation in biopharma and healthcare. The technology’s adoption is expected to drive advancements in drug development, functional foods, and wellness products, contributing to a more sustainable and health-conscious future.
Source: Bio Spectrum
The collaboration focuses on scaling up the production of high-purity C-PC using IIT-G’s advanced biotechnological innovations. This sustainable, cost-effective production method enhances the commercial viability of C-PC, paving the way for its widespread use in therapeutic formulations, immune-boosting supplements, and anti-cancer treatments.
Researchers at IIT-G highlight the growing global demand for natural, plant-based bioactive compounds, positioning C-PC as a promising alternative to synthetic dyes and pharmaceutical additives. The MoU aims to facilitate industry partnerships, enabling mass production and commercialization of this high-value biomolecule.
Through this initiative, IIT-G reinforces its commitment to bridging scientific research with industry applications, fostering innovation in biopharma and healthcare. The technology’s adoption is expected to drive advancements in drug development, functional foods, and wellness products, contributing to a more sustainable and health-conscious future.
Source: Bio Spectrum
The Indian Institute of Technology Guwahati (IIT-G) has signed a Memorandum of Understanding (MoU) to promote its cutting-edge C-Phycocyanin (C-PC) production technology, aiming to revolutionize the health and pharmaceutical industries. C-Phycocyanin, a natural blue pigment derived from Spirulina, is known for its potent antioxidant, anti-inflammatory, and neuroprotective properties, making it highly valuable for pharmaceutical, nutraceutical, and cosmetic applications.
The collaboration focuses on scaling up the production of high-purity C-PC using IIT-G’s advanced biotechnological innovations. This sustainable, cost-effective production method enhances the commercial viability of C-PC, paving the way for its widespread use in therapeutic formulations, immune-boosting supplements, and anti-cancer treatments.
Researchers at IIT-G highlight the growing global demand for natural, plant-based bioactive compounds, positioning C-PC as a promising alternative to synthetic dyes and pharmaceutical additives. The MoU aims to facilitate industry partnerships, enabling mass production and commercialization of this high-value biomolecule.
Through this initiative, IIT-G reinforces its commitment to bridging scientific research with industry applications, fostering innovation in biopharma and healthcare. The technology’s adoption is expected to drive advancements in drug development, functional foods, and wellness products, contributing to a more sustainable and health-conscious future.
Source: Bio Spectrum
